Slingshot members are tracking this event:
Phase 1/2 trial updated data of LentiGlobin for β-Thalassemia and Sickle Disease expected at ASH December 2016
Slingshot Insights Explained
Dec 05, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 1/2 Trial, Lentiglobin, Beta-thalassemia, Ash 2016